Elon Musk’s Neuralink gets FDA green light for second patient
![]() 7069 Tuesday, 21 May, 2024, 10:24 The U.S. Food and Drug Administration gave a green light to Elon Musk’s Neuralink to implant its brain chip in a second person, signing off on the company’s proposed fixes for a problem that occurred in the first test participant. Earlier this month, Neuralink said tiny wires implanted in the brain of its first patient had pulled out of position. Reuters reported last week, citing sources, the company knew from animal testing that the wires might retract. The company intends to fix the problem by embedding some of the device's wires deeper into the brain, the WSJ report said citing a person familiar with the company and a document it had viewed. |
Elon Musk’s Neuralink gets FDA green light for second patient
706521.05.2024, 10:24SpaceX Starship ‘Lost’ After Reaching Space During Third Test Flight
1476214.03.2024, 20:27Neuralink's first human patient can control mouse through thinking, says Elon Musk
1760420.02.2024, 15:24A Bronze Age lip-paint from southeastern Iran (photo)
1827406.02.2024, 20:24Apple thinks iOS 18 might be the ‘biggest’ iOS update ever
1779803.02.2024, 20:06Elon Musk's Neuralink implants brain chip in first human (video)
1675630.01.2024, 10:30Nokia smartphone brand will soon disappear: Why has it failed to gain a place in the market?
1841218.01.2024, 23:48For the first time in 30 years, your keyboard is about to be changed (video)
1970105.01.2024, 17:24